Additionally, 76% reported improved memory and focus, while 63% reported weight loss.* But those are just the benefits you can notice from a self-evaluation
[17] [18] However, acid reflux or heartburn is not consistently reported as a distinct adverse event category in pivotal trials
With the influx of GLP-1 weight loss drugs, many users are noticing significant changes to their facial appearance and skin
10.1038/srep32893 Sci
Because c-Myc mediated miR-23a and miR-23b repression, overexpression of c-MYC can upregulate GLS, and therefore promote glutaminolysis (Gao et al., 2009) (Figure 2)
For example, with reference to the clinical ocular trials mentioned in Sosne and Kleinman, the researchers noted that no long-term safety studies have been done with TI34 treatment in the eye for more than a month